OYAMA RIEKO 小山理恵子

… Alternative Names

小山理恵子オヤマリエコ

Less

Researcher Number	40327713
Other IDs	https://orcid.org/0000-0003-0130-6776
Affiliation (Current)	2025: 杏林大学, 医学部, 特任助教
Affiliation (based on the past Project Information) *help	2018 – 2020: 国立研究開発法人国立がん研究センター, 研究所, 特任研究員
Review Section/Research Field	Except Principal Investigator Basic Section 56020:Orthopedics-related
Keywords	Except Principal Investigator 次世代シークエンサー / 個別化医療 / 抗がん剤 / ゲノム / 悪性骨軟部腫瘍 / 細胞株 / 患者由来がんモデル / 治療標的 / バイオマーカー / ゲノミクス … More / プロテオミクス / 質量分析 / 肉腫 / プロテオゲノミクス Less

Development and application of new biomarkers of malignant bone and soft tissue tumors (sarcomas) using the method of proteogenomics analysis
- Principal Investigator
  
  KAWAI AKIRA
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56020:Orthopedics-related
- Research Institution
  National Cancer Center Japan

All 2020 2019

All Journal Article

[Journal Article] Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 042020
- Author(s)
  Chin Motoaki、Yokoyama Ryohei、Sumi Minako、Okita Hajime、Kawai Akira、Hosono Ako、Koga Yuhki、Sano Hideki、Watanabe Hiroyoshi、Ozaki Toshifumi、Mugishima Hideo、Japan Ewing Sarcoma Study Group (JESS)
- Journal Title
  
  Pediatric Blood & Cancer
  
  Volume: 67 Issue: 5
- DOI
  10.1002/pbc.28194
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02933
[Journal Article] Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors2020
- Author(s)
  Oyama Rieko、Kito Fusako、Takahashi Mami、Hattori Emi、Noguchi Rei、Takai Yoko、Sakumoto Marimu、Qiao Zhiwei、Toki Shunichi、Sugawara Masato、Tanzawa Yoshikazu、Kobayashi Eisuke、Nakatani Fumihiko、Iwata Shintaro、Yoshida Akihiko、Kawai Akira、Kondo Tadashi
- Journal Title
  
  Cancer Cell International
  
  Volume: 20 Issue: 1 Pages: 58-58
- DOI
  10.1186/s12935-020-1128-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02933
[Journal Article] Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma2019
- Author(s)
  Nakagawa M, Nakatani F, Matsunaga H, Seki T, Endo M, Ogawara Y, Machida Y, Katsumoto T, Yamagata K, Hattori A, Fujita S, Aikawa Y, Ishikawa T, Soga T, Kawai A, Chuman H, Yokoyama N, Fukushima S, Yahiro K, Kimura A, Shimada E, Hirose T, Fujiwara T, et. al
- Journal Title
  
  Oncogene
  
  Volume: 38 Issue: 42 Pages: 6835-6849
- DOI
  10.1038/s41388-019-0929-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K16626, KAKENHI-PROJECT-18H02933
[Journal Article] Species-Specific Quantitative Proteomics Profiles of Sarcoma Patient-Derived Models Closely Reflect Their Primary Tumors.2019
- Author(s)
  Shiozawa K, Oyama R, Takahashi M, Kito F, Hattori E, Yoshida A, Kawai A, Ono M, Kondo T.
- Journal Title
  
  Proteomics Clin Appl
  
  Volume: Nov;13(6) Issue: 6 Pages: 1900054-1900054
- DOI
  10.1002/prca.201900054
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07791, KAKENHI-PLANNED-17H06419, KAKENHI-PROJECT-18H02933
[Journal Article] Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study2019
- Author(s)
  Koike Hiroshi、Nishida Yoshihiro、Kohno Kei、Shimoyama Yoshie、Motoi Toru、Hamada Shunsuke、Kawai Akira、Ogose Akira、Ozaki Toshifumi、Kunisada Toshiyuki、Matsumoto Yoshihiro、Matsunobu Tomoya、Ae Keisuke、Gokita Tabu、Sakai Tomohisa、Shimizu Koki、Ishiguro Naoki
- Journal Title
  
  Human Pathology
  
  Volume: 84 Pages: 155-163
- DOI
  10.1016/j.humpath.2018.09.018
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15313, KAKENHI-PROJECT-17H01585, KAKENHI-PROJECT-16K20047, KAKENHI-PROJECT-18H02933

1. KAWAI AKIRA (90252965)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
2. 近藤格 (30284061)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
3. 市川仁 (30201924)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 吉田朗彦 (80574780)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
5. 野口玲 (30779682)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. 吉松有紀 (60808632)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 服部恵美 (30815006)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. HAMADA Shunsuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 藤原稔史

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

OYAMA RIEKO 小山理恵子

小山理恵子オヤマリエコ

Research Projects

Research Products

Co-Researchers

Development and application of new biomarkers of malignant bone and soft tissue tumors (sarcomas) using the method of proteogenomics analysis

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 042020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Species-Specific Quantitative Proteomics Profiles of Sarcoma Patient-Derived Models Closely Reflect Their Primary Tumors.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study2019

Author(s)

Journal Title

DOI

Data Source

OYAMA RIEKO 小山 理恵子

小山 理恵子 オヤマ リエコ

Research Projects

Research Products

Co-Researchers

Development and application of new biomarkers of malignant bone and soft tissue tumors (sarcomas) using the method of proteogenomics analysis

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 042020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Species-Specific Quantitative Proteomics Profiles of Sarcoma Patient-Derived Models Closely Reflect Their Primary Tumors.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study2019

Author(s)

Journal Title

DOI

Data Source

OYAMA RIEKO 小山理恵子

小山理恵子オヤマリエコ